Zhejiang Hisoar Pharmaceutical Co Ltd (002099) — Financial Flexibility Index
Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥31.99 Million (operating CF CN¥15.48 Million minus capex CN¥16.52 Million) represents 0% of total liabilities (CN¥2.17 Billion). Check 002099 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Hisoar Pharmaceutical Co Ltd Financial Flexibility Index (2003–2024)
Historical Financial Flexibility Index trend for Zhejiang Hisoar Pharmaceutical Co Ltd across 22 annual periods. See Zhejiang Hisoar Pharmaceutical Co Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)
Year-by-year free cash flow to debt coverage for Zhejiang Hisoar Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Zhejiang Hisoar Pharmaceutical Co Ltd market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.13x | CN¥296.94 Million | CN¥174.83 Million | CN¥2.32 Billion | ▼ -37.7% |
| 2023 | 0.21x | CN¥393.61 Million | CN¥240.54 Million | CN¥1.92 Billion | ▲ +58.9% |
| 2022 | 0.13x | CN¥295.52 Million | CN¥116.09 Million | CN¥2.29 Billion | ▼ -25.8% |
| 2021 | 0.17x | CN¥331.92 Million | CN¥102.36 Million | CN¥1.91 Billion | ▼ -62.0% |
| 2020 | 0.46x | CN¥608.05 Million | CN¥533.87 Million | CN¥1.33 Billion | ▼ -39.4% |
| 2019 | 0.76x | CN¥773.04 Million | CN¥612.40 Million | CN¥1.02 Billion | ▲ +18.7% |
| 2018 | 0.64x | CN¥1.05 Billion | CN¥791.45 Million | CN¥1.64 Billion | ▲ +488.2% |
| 2017 | 0.11x | CN¥251.67 Million | CN¥102.68 Million | CN¥2.32 Billion | ▼ -69.3% |
| 2016 | 0.35x | CN¥753.73 Million | CN¥629.42 Million | CN¥2.14 Billion | ▼ -41.5% |
| 2015 | 0.60x | CN¥758.52 Million | CN¥462.16 Million | CN¥1.26 Billion | ▲ +65.3% |
| 2014 | 0.36x | CN¥360.62 Million | CN¥191.56 Million | CN¥988.73 Million | ▲ +57.2% |
| 2013 | 0.23x | CN¥342.64 Million | CN¥60.85 Million | CN¥1.48 Billion | ▼ -54.9% |
| 2012 | 0.51x | CN¥607.51 Million | CN¥180.73 Million | CN¥1.18 Billion | ▲ +15.9% |
| 2011 | 0.44x | CN¥310.14 Million | CN¥92.62 Million | CN¥698.17 Million | ▼ -31.8% |
| 2010 | 0.65x | CN¥327.39 Million | CN¥180.88 Million | CN¥502.28 Million | ▲ +86.3% |
| 2009 | 0.35x | CN¥151.98 Million | CN¥98.38 Million | CN¥434.48 Million | ▲ +34.6% |
| 2008 | 0.26x | CN¥121.01 Million | CN¥30.61 Million | CN¥465.58 Million | ▼ -34.7% |
| 2007 | 0.40x | CN¥163.75 Million | CN¥51.14 Million | CN¥411.69 Million | ▼ -2.6% |
| 2006 | 0.41x | CN¥164.47 Million | CN¥61.88 Million | CN¥402.66 Million | ▲ +46.5% |
| 2005 | 0.28x | CN¥109.81 Million | CN¥36.07 Million | CN¥393.76 Million | ▼ -16.1% |
| 2004 | 0.33x | CN¥84.90 Million | CN¥42.36 Million | CN¥255.35 Million | ▲ +139.6% |
| 2003 | 0.14x | CN¥38.48 Million | CN¥-5.45 Million | CN¥277.36 Million | — |